These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25003616)

  • 41. Difficulties in diagnosing severe Pneumocystis jiroveci pneumonia after rituximab therapy for steroid-dependent nephrotic syndrome.
    Czarniak P; Załuska-Leśniewska I; Zagożdżon I; Zurowska A
    Pediatr Nephrol; 2013 Jun; 28(6):987-8. PubMed ID: 23549855
    [No Abstract]   [Full Text] [Related]  

  • 42. Levamisole in Frequently-relapsing and Steroid-dependent Nephrotic Syndrome.
    Kiruba Samuel EM; Krishnamurthy S; Bhanudeep S; Muske S
    Indian Pediatr; 2017 Oct; 54(10):831-834. PubMed ID: 28699616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial.
    Hogan J; Perez A; Sellier-Leclerc AL; Vrillon I; Broux F; Nobili F; Harambat J; Bessenay L; Audard V; Faudeux C; Morin D; Pietrement C; Tellier S; Djeddi D; Eckart P; Lahoche A; Roussey-Kesler G; Ulinski T; Boyer O; Plaisier E; Cloarec S; Jolivot A; Guigonis V; Guilmin-Crepon S; Baudouin V; Dossier C; Deschênes G
    BMJ Open; 2020 Sep; 10(9):e037306. PubMed ID: 32967877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children.
    Kamei K; Ito S; Nozu K; Fujinaga S; Nakayama M; Sako M; Saito M; Yoneko M; Iijima K
    Pediatr Nephrol; 2009 Jul; 24(7):1321-8. PubMed ID: 19421786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rituximab in steroid-dependent nephrotic syndrome.
    El Koumi M
    Iran J Kidney Dis; 2013 Nov; 7(6):502-6. PubMed ID: 24241100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-steroidal and non-cytotoxic therapies for nephrotic syndrome.
    Coppo R
    Nephrol Dial Transplant; 2008 Jun; 23(6):1793-6. PubMed ID: 18441003
    [No Abstract]   [Full Text] [Related]  

  • 47. Rituximab treatment for adult purpura nephritis with nephrotic syndrome.
    Ishiguro H; Hashimoto T; Akata M; Suzuki S; Azushima K; Kobayashi Y; Kanaoka T; Yoshida S; Wakui H; Oshikawa J; Nagahama K; Inayama Y; Tamura K; Toya Y; Umemura S
    Intern Med; 2013; 52(10):1079-83. PubMed ID: 23676594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Rituximab for the treatment of nephrotic syndrome].
    Iijima K
    Nihon Jinzo Gakkai Shi; 2014; 56(4):471-7. PubMed ID: 24956878
    [No Abstract]   [Full Text] [Related]  

  • 49. Rituximab-induced serum sickness in a 6-year-old boy with steroid-dependent nephrotic syndrome.
    Nakamura M; Kanda S; Yoshioka Y; Takahashi C; Owada K; Kajiho Y; Harita Y; Oka A
    CEN Case Rep; 2020 May; 9(2):173-176. PubMed ID: 31970629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children.
    Kamei K; Ishikura K; Sako M; Ito S; Nozu K; Iijima K
    Pediatr Nephrol; 2020 Jan; 35(1):17-24. PubMed ID: 30564879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.
    Van Horebeek I; Knops N; Van Dyck M; Levtchenko E; Mekahli D
    Acta Clin Belg; 2017 Jun; 72(3):147-155. PubMed ID: 27409338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rituximab in childhood lupus myocarditis.
    Aggarwal P; Singh S; Suri D; Rawat A; Narula N; ManojKumar R
    Rheumatol Int; 2012 Jun; 32(6):1843-4. PubMed ID: 21468728
    [No Abstract]   [Full Text] [Related]  

  • 54. Rituximab in treatment of idiopathic glomerulopathy.
    El-Reshaid K; Sallam HT; Hakim AA; Al-Attiyah R
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):973-8. PubMed ID: 22982909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The uncertainty of rituximab and steroid dosing in refractory steroid-resistant nephrotic syndrome.
    Hirano D; Fujinaga S; Nishizaki N
    Clin Nephrol; 2012 Jun; 77(6):510-2. PubMed ID: 22595396
    [No Abstract]   [Full Text] [Related]  

  • 56. [Idiopathic nephrotic syndrome in children: from corticosteroids to rituximab].
    Deschênes G
    Arch Pediatr; 2011 Aug; 18(8):843-5. PubMed ID: 21719260
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome.
    Parmentier C; Delbet JD; Decramer S; Boyer O; Hogan J; Ulinski T
    Pediatr Nephrol; 2020 Mar; 35(3):455-462. PubMed ID: 31705306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.
    Vivarelli M; Colucci M; Bonanni A; Verzani M; Serafinelli J; Emma F; Ghiggeri G
    Pediatr Nephrol; 2017 Jan; 32(1):181-184. PubMed ID: 27687621
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mycophenolate Sodium for Children with Frequently Relapsing or Steroid Dependent Nephrotic Syndrome.
    Kapoor K; Saha A; Kaur M; Dubey NK; Upadhyay AD
    Indian Pediatr; 2017 Oct; 54(10):885-886. PubMed ID: 29120340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ofatumumab for rituximab-resistant nephrotic syndrome.
    Basu B
    N Engl J Med; 2014 Mar; 370(13):1268-70. PubMed ID: 24670185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.